Latest Breaking News On - மேத்யூ ஹோவெல் - Page 1 : comparemela.com
Girls, Boys State candidates from Dover
timesreporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesreporter.com Daily Mail and Mail on Sunday newspapers.
Horrigan & Howell: A Sketch Too Far at The Hope Theatre
londontheatre1.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from londontheatre1.com Daily Mail and Mail on Sunday newspapers.
Mark Davis Howell
dnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dnews.com Daily Mail and Mail on Sunday newspapers.
Luis Alvarez
Big pharmaceutical companies can still take legal action if the World Trade Organization decides to waive patent rights on Covid-19 vaccines.
But their options - especially outside the US - are limited.
And they have to decide if the optics are worth it, after a decision to file a lawsuit in South Africa challenging cheaper Aids drugs backfired.
A potential World Trade Organization (WTO) waiver of patent and trade secret protections for Covid-19 vaccines would leave pharmaceutical companies with limited legal avenues to recover costs.
The US on Wednesday expressed support for a temporary waiver, sending shares in several vaccine makers down the next day. The issue now faces thorny negotiations at the WTO, where several members, including Germany, have opposed efforts to skirt intellectual property rights. They say it would only complicate production and make companies less likely to respond in the future.
If Covid-19 Vaccine Patents Are Waived, Legal Options For Drug Firms Are Limited By Ian Lopez and Tina Davis | May 7, 2021
A potential World Trade Organization waiver of patent and trade secret protections for Covid-19 vaccines would leave pharmaceutical companies with limited legal avenues to recover costs.
The U.S. on Wednesday expressed support for a temporary waiver, sending shares in several vaccine makers down the next day. The issue now faces thorny negotiations at the WTO, where several members, including Germany, have opposed efforts to skirt intellectual property rights. They say it would only complicate production and make companies less likely to respond in the future.